A Multiple Centre, Cohort Study of New CRRT Membranes oXiris for Patients With Septic Shock

NCT04073771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 590

Last updated 2022-12-02

No results posted yet for this study

Summary

The objectives of this study are to determine whether Continuous Renal Replacement Therapy (CRRT) with oXiris in patients with septic shock would improve clinical outcomes such as the sepsis-related organ failure assessment (SOFA) , hemodynamic, mortality compared CRRT with conventional membrane.

Conditions

  • Acute Kidney Injury Due to Sepsis (Disorder)

Interventions

DEVICE

Continuous renal replacement therapy with oXiris

Continuous renal replacement therapy with oXiris in patient with septic shock

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY
  • Southeast University, China

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-21
Primary Completion
2021-06-30
Completion
2021-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04073771 on ClinicalTrials.gov